← Back to Clinical Trials
Recruiting NCT06941727

NCT06941727 Relationship Between Mouth Opening and Masseter Elasticity in Oral Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06941727
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Oral Cancer
Study Type OBSERVATIONAL
Enrollment 10 participants
Start Date 2025-05-16
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
ultrasonographic imaging

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10 participants in total. It began in 2025-05-16 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to assess the hardness of masticatory muscles in post-surgical oral cancer patients using strain elastography ultrasound, calculating the masseter elasticity index and exploring its association with maximum interincisal mouth opening. Furthermore, the study incorporates exercise training to analyze whether changes in masseter hardness can serve as an objective indicator for predicting the improvement of trismus.

Eligibility Criteria

Inclusion Criteria: 1. Newly diagnosed oral cancer patients who are scheduled to receive cancer-related treatments (e.g., oral cancer surgery, radiotherapy, chemotherapy, or chemoradiotherapy). 2. Age between 20 and 65 years. Exclusion Criteria: 1. Could not communicate. 2. Had any disorder that could influence movement performance.

Contact & Investigator

Central Contact

Yueh-Hsia Chen, PhD

✉ yuehhsiachen@ntu.edu.tw

📞 +886-2-33668133

Principal Investigator

Yueh-Hsia Chen, PhD

PRINCIPAL INVESTIGATOR

National Taiwan University, College of Medicine

Frequently Asked Questions

Who can join the NCT06941727 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Oral Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06941727 currently recruiting?

Yes, NCT06941727 is actively recruiting participants. Contact the research team at yuehhsiachen@ntu.edu.tw for enrollment information.

Where is the NCT06941727 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT06941727 clinical trial?

NCT06941727 is sponsored by National Taiwan University Hospital. The principal investigator is Yueh-Hsia Chen, PhD at National Taiwan University, College of Medicine. The trial plans to enroll 10 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology